HK1119244A1 - Detecting and predicting pre-eclampsia - Google Patents

Detecting and predicting pre-eclampsia

Info

Publication number
HK1119244A1
HK1119244A1 HK08112797.2A HK08112797A HK1119244A1 HK 1119244 A1 HK1119244 A1 HK 1119244A1 HK 08112797 A HK08112797 A HK 08112797A HK 1119244 A1 HK1119244 A1 HK 1119244A1
Authority
HK
Hong Kong
Prior art keywords
eclampsia
detecting
predicting
predicting pre
technology described
Prior art date
Application number
HK08112797.2A
Other languages
English (en)
Inventor
Lucilla Poston
Andrew Shennan
Original Assignee
Perkinelmer Las Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Perkinelmer Las Inc filed Critical Perkinelmer Las Inc
Publication of HK1119244A1 publication Critical patent/HK1119244A1/xx

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/475—Assays involving growth factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/715—Assays involving receptors, cell surface antigens or cell surface determinants for cytokines; for lymphokines; for interferons
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
    • G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
    • G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
    • G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
    • G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
    • G01N2333/96486—Metalloendopeptidases (3.4.24)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/36—Gynecology or obstetrics
    • G01N2800/368—Pregnancy complicated by disease or abnormalities of pregnancy, e.g. preeclampsia, preterm labour

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Reproductive Health (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Mold Materials And Core Materials (AREA)
  • Optical Fibers, Optical Fiber Cores, And Optical Fiber Bundles (AREA)
  • Adhesives Or Adhesive Processes (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Holo Graphy (AREA)
HK08112797.2A 2006-01-17 2008-11-21 Detecting and predicting pre-eclampsia HK1119244A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0600916.1A GB0600916D0 (en) 2006-01-17 2006-01-17 detecting and predicting pre-eclampsia
PCT/GB2007/000123 WO2007083099A1 (en) 2006-01-17 2007-01-17 Detecting and predicting pre-eclampsia

Publications (1)

Publication Number Publication Date
HK1119244A1 true HK1119244A1 (en) 2009-02-27

Family

ID=35998177

Family Applications (1)

Application Number Title Priority Date Filing Date
HK08112797.2A HK1119244A1 (en) 2006-01-17 2008-11-21 Detecting and predicting pre-eclampsia

Country Status (11)

Country Link
US (1) US7638287B2 (xx)
EP (1) EP1974220B1 (xx)
JP (1) JP2009524014A (xx)
AT (1) ATE504002T1 (xx)
AU (1) AU2007206756B2 (xx)
CA (1) CA2602681C (xx)
DE (1) DE602007013524D1 (xx)
ES (1) ES2364314T3 (xx)
GB (1) GB0600916D0 (xx)
HK (1) HK1119244A1 (xx)
WO (1) WO2007083099A1 (xx)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL2111555T3 (pl) 2007-02-12 2013-10-31 A1M Pharma Ab Diagnostyka stanu przedrzucawkowego
GB0715030D0 (en) * 2007-08-02 2007-09-12 Wilson Carol J Testing process
CN102216468B (zh) * 2008-01-25 2014-06-11 珀金埃尔默健康科学股份有限公司 确定产前并发症风险的方法
WO2010059952A1 (en) * 2008-11-20 2010-05-27 Perkinelmer Health Sciences, Inc. Method for determining the risk of preeclampsia using pigf-2 and pigf-3 markers
WO2010091253A1 (en) 2009-02-06 2010-08-12 Women & Infants' Hospital Of Rhode Island Compositions, formulations and methods of treating preeclampsia-type disorders of pregnancy
JP5926722B2 (ja) * 2010-03-24 2016-05-25 プリールミナ ダイアグノスティックス エービーＰｒｅｅｌｕｍｉｎａ Ｄｉａｇｎｏｓｔｉｃｓ Ａｂ 子癇前症の初期段階マーカーとしてのＨｂＦおよびＡ１Ｍ
US20140349881A1 (en) * 2011-12-15 2014-11-27 Pronota N.V. Biomarkers and parameters for preeclampsia
CN104380104B (zh) * 2012-04-24 2021-03-30 西门子医疗保健诊断公司 先兆子痫筛查法
MX2015010174A (es) * 2013-02-08 2016-03-31 Univ Iowa Res Found Herramientas de diagnostico para predecir la presentacion de preeclampsia.
US10119978B2 (en) * 2013-03-15 2018-11-06 Wallac Oy System and method for determining risk of diabetes based on biochemical marker analysis
US10656163B2 (en) 2014-09-02 2020-05-19 Wallac Oy Method for determining risk of pre-eclampsia
US20200395127A1 (en) * 2017-11-17 2020-12-17 University Of Washington Connected system for information-enhanced test results
EP4070113A4 (en) 2019-12-04 2023-12-20 Biora Therapeutics, Inc. ASSESSMENT OF PREECAMPSIA USING FREE AND DISSOCIATE PLACENTAL GROWTH FACTOR ASSAYS
WO2022173786A1 (en) * 2021-02-10 2022-08-18 Mirvie, Inc. Methods and systems for conducting pregnancy-related clinical trials

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2275708A1 (en) 1996-12-23 1998-07-02 Cambridge University Technical Services Limited Diagnosis and treatment of pathological pregnancies
GB0026823D0 (en) 2000-11-02 2000-12-20 King S College London Diagnosis of pre-eclampsia
US7435419B2 (en) * 2002-07-19 2008-10-14 Beth Israel Deaconess Medical Center Methods of diagnosing and treating pre-eclampsia or eclampsia
GB0308967D0 (en) * 2003-04-17 2003-05-28 Univ London Screen for pre-eclampsia
CA2539430C (en) * 2003-09-23 2015-03-17 The General Hospital Corporation Screening for gestational disorders with sex hormone binding globulin as biomarker
CA2485722A1 (en) * 2003-10-22 2005-04-22 Paul Lehmann Soluble transferrin receptor

Also Published As

Publication number Publication date
EP1974220B1 (en) 2011-03-30
US7638287B2 (en) 2009-12-29
ES2364314T3 (es) 2011-08-31
CA2602681C (en) 2017-03-14
AU2007206756A1 (en) 2007-07-26
US20070178530A1 (en) 2007-08-02
GB0600916D0 (en) 2006-02-22
ATE504002T1 (de) 2011-04-15
JP2009524014A (ja) 2009-06-25
DE602007013524D1 (de) 2011-05-12
AU2007206756B2 (en) 2011-06-16
ES2364314T8 (es) 2011-09-22
WO2007083099A1 (en) 2007-07-26
EP1974220A1 (en) 2008-10-01
CA2602681A1 (en) 2007-07-26

Similar Documents

Publication Publication Date Title
HK1119244A1 (en) Detecting and predicting pre-eclampsia
WO2012021795A3 (en) Pancreatic cancer biomarkers and uses thereof
WO2009048530A3 (en) Highly multiplexed particle-based assays
WO2010129934A3 (en) Methods and compositions for diagnosis of thyroid conditions
WO2008061104A3 (en) Methods and kits for detecting prostate cancer biomarkers
WO2009129505A3 (en) Compositions, methods, and kits using synthetic probes for determining the presence of a target nucleic acid
WO2007100506A3 (en) Mass tags for quantitative analyses
WO2008024473A3 (en) Mapping of genomic interactions
WO2009037572A3 (en) Biomarker combinations for colorectal cancer
NZ605698A (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
WO2012037937A3 (de) Verfahren zum nachweis, differenzieren und quantifizieren von t-zellpopulationen mittels der reverse transkription quantitativen real-time pcr (rt-qpcr) technologie
WO2010075360A3 (en) Methods for detection of sepsis
WO2010092164A3 (en) Bacterial dna as markers of cardiovascular and/or metabolic disease
WO2011142781A3 (en) Pore-limit electrophoresis (ple) microchannel assays
EP2011868A4 (en) MODIFIED CREATININAMIDE HYDROLASE WITH IMPROVED SUBSTRATEFFINITY AND REAGENT COMPOSITION FOR THE DETERMINATION OF CREATININE
MX2009010751A (es) Composiciones y metodos de deteccion.
DK2118666T3 (da) Fremgangsmåde til normalisering af koncentrationen af analytter i en urinprøve
MX2009004852A (es) Procedimiento para la determinacion de la fragmentacion del adn en microorganismos.
WO2008034622A3 (en) A method of detecting and/or quantifying expression of a target protein candidate in a cell, and a method of identifying a target protein of a small molecule modulator
TW200745551A (en) Device and methods for detecting and quantifying one or more target agents
WO2009092982A3 (fr) Procédé de détection et/ou d'identification de clostridium difficile
WO2009007649A3 (fr) Dispositif et procede d'identification et de determination de groupes sanguins
AU2006254891A8 (en) Compositions, methods and kits for determining the presence of Chlamydophila pneumoniae in a test sample
WO2006099537A3 (en) The use of antibody-surrogate antigen systems for detection of analytes
WO2009126889A8 (en) Assays for detecting pregnancy-associated glycoproteins